Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medi-diagnostic solutions (m) sdn. bhd. - meglumine ioxitalamate -

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove pharma australia pty limited - flunixin meglumine - parenteral liquid/solution/suspension - flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antiprostaglandin | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling

Egyesült Államok - angol - NLM (National Library of Medicine)

melinta therapeutics, llc - delafloxacin meglumine (unii: n7v53u4u4t) (delafloxacin - unii:6315412yvf) - delafloxacin 450 mg - baxdela is indicated in adults for the treatment of acute bacterial skin and skin structure infections (absssi) caused by the following susceptible microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), staphylococcus haemolyticus, staphylococcus lugdunensis, streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), streptococcus pyogenes , enterococcus faecalis , escherichia coli, enterobacter cloacae, klebsiella pneumoniae, and pseudomonas aeruginosa. baxdela is indicated in adults for the treatment of community-acquired bacterial pneumonia (cabp) caused by the following susceptible microorganisms: streptococcus pneumoniae, staphylococcus aureus (methicillin-susceptible [mssa] isolates only), klebsiella pneumoniae , escherichia coli, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae , chlamydia pneumoniae , legione

Egyesült Államok - angol - NLM (National Library of Medicine)

henry schein animal health - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: flunixiject™ injectable solution is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixiject™ injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixiject™ injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of

Egyesült Államok - angol - NLM (National Library of Medicine)

norbrook laboratories limited - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

Egyesült Államok - angol - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse :  flunazine® injectable solution is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.  it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle :  flunazine® injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis.  flunazine® injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse :  there are no known contraindications to this drug when used as directed.  intra-arterial injection should be avoided.  horses inadvertently injected intra-arterially can show adverse reactions.  signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness.  signs are transient and disappear without antidotal medication within a few minutes.  do not use in horses showing hypersensitivity to flunixin meglumine. cattle :  nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunazine® injectable solution within 48 hours of expected parturition.  do not use in animals showing hypersensitivity to flunixin meglumine.  use judiciously when renal impairment or gastric ulceration are suspected.

Egyesült Államok - angol - NLM (National Library of Medicine)

merck sharp & dohme - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - indications horse: banamine (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: banamine (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. banamine is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostag

Egyesült Államok - angol - NLM (National Library of Medicine)

agri laboratories, ltd - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - flunixin meglumine 50 mg in 1 ml - horse :  flu-nix is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.  it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle :  flu-nix is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis.   flu-nix is also indicated for the control of inflammation in endotoxemia. horse : there are no known contraindications to this drug when used as directed.  intra-arterial injection should be avoided.  horses inadvertently injected intra-arterial can show adverse reactions.  signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness.  signs are transient and disappear without antidotal medication within a few minutes.  do not use in horses showing hypersensitivity to flunixin meglumine. cattle :  there are no known contraindications to this drug in cattle when used as directed.  do not use in animals showing hypersensi

Egyesült Államok - angol - NLM (National Library of Medicine)

ax pharmaceutical corp - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin meglumine - unii:8y3jk0jw3u) - flunixin meglumine 495 g in 500 g

Egyesült Államok - angol - NLM (National Library of Medicine)

amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 60 g in 100 ml - hypaque meglumine 60 percent is indicated for excretory urography; cerebral angiography; peripheral arteriography; venography; operative, t-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography; discography; and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration-excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures. visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancie